Trials / Conditions / Neuroendocrine Neoplasm of Lung
Neuroendocrine Neoplasm of Lung
4 registered clinical trials studyying Neuroendocrine Neoplasm of Lung — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Risk Factors for Neuroendocrine Neoplasms NCT06282016 | Bavarian Cancer Registry | — |
| Recruiting | Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients NCT06523582 | Universidad Nacional Autonoma de Mexico | — |
| Unknown | Everolimus TDM to Predict Long Term Toxicity NCT03033186 | Maastricht University Medical Center | — |
| Completed | Durvalumab (MEDI4736) Plus Tremelimumab for Advanced Neuroendocrine Neoplasms of Gastroenteropancreatic or Lun NCT03095274 | Grupo Espanol de Tumores Neuroendocrinos | Phase 2 |